Titan Biotech Limited (TITANBIO.BO)

INR 781.0

(1.07%)

Long Term Debt Summary of Titan Biotech Limited

Titan Biotech Limited's latest annual long term debt in 2023 was 4.53 Million INR , down -68.33% from previous year.
Titan Biotech Limited's latest quarterly long term debt in 2023 FY was 4.53 Million INR , down -68.33% from previous quarter.
Titan Biotech Limited reported annual long term debt of 14.31 Million INR in 2022, down -85.61% from previous year.
Titan Biotech Limited reported annual long term debt of 99.45 Million INR in 2021, up 59.04% from previous year.
Titan Biotech Limited reported quarterly long term debt of 22.83 Million INR for 2023 Q2, down 0.0% from previous quarter.
Titan Biotech Limited reported quarterly long term debt of 4.53 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Titan Biotech Limited (2023 - 2008)

Historical Annual Long Term Debt of Titan Biotech Limited (2023 - 2008)

Year	Long Term Debt	Long Term Debt Growth
2023	4.53 Million INR	-68.33%
2022	14.31 Million INR	-85.61%
2021	99.45 Million INR	59.04%
2020	62.53 Million INR	-45.87%
2019	115.53 Million INR	-12.25%
2018	131.66 Million INR	-26.33%
2017	178.71 Million INR	17.77%
2016	151.74 Million INR	254.87%
2015	42.75 Million INR	94.81%
2014	21.94 Million INR	-43.91%
2013	39.13 Million INR	95.06%
2012	20.06 Million INR	107.15%
2011	9.68 Million INR	-64.59%
2010	27.35 Million INR	113.32%
2009	12.82 Million INR	158.0%
2008	4.96 Million INR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2023 Q3	- INR	-100.0%
2023 Q2	22.83 Million INR	0.0%
2023 Q4	4.53 Million INR	0.0%
2023 FY	4.53 Million INR	-68.33%
2023 Q1	- INR	-100.0%
2022 Q4	14.31 Million INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q2	26.98 Million INR	-15.26%
2022 Q1	31.84 Million INR	-67.98%
2022 FY	14.31 Million INR	-85.61%
2021 Q2	86.38 Million INR	-2.08%
2021 Q1	88.21 Million INR	41.07%
2021 FY	99.45 Million INR	59.04%
2021 Q4	99.45 Million INR	-6.94%
2021 Q3	106.87 Million INR	23.72%
2020 Q1	148.82 Million INR	28.81%
2020 Q3	40.32 Million INR	-68.81%
2020 FY	62.53 Million INR	-45.87%
2020 Q4	62.53 Million INR	55.1%
2020 Q2	129.26 Million INR	-13.14%
2019 Q2	124.79 Million INR	0.0%
2019 FY	115.53 Million INR	-12.25%
2019 Q4	115.53 Million INR	0.0%
2018 Q2	176.77 Million INR	0.0%
2018 FY	131.66 Million INR	-26.33%
2018 Q4	131.66 Million INR	0.0%
2017 Q4	178.71 Million INR	0.0%
2017 FY	178.71 Million INR	17.77%
2017 Q2	154.11 Million INR	0.0%
2016 Q2	51.08 Million INR	0.0%
2016 FY	151.74 Million INR	254.87%
2016 Q4	151.74 Million INR	0.0%
2015 Q4	42.75 Million INR	0.0%
2015 Q2	22.79 Million INR	0.0%
2015 FY	42.75 Million INR	94.81%
2014 Q4	21.94 Million INR	0.0%
2014 FY	21.94 Million INR	-43.91%
2013 FY	39.13 Million INR	95.06%
2013 Q2	18.3 Million INR	0.0%
2013 Q4	39.13 Million INR	0.0%
2012 Q4	20.06 Million INR	0.0%
2012 FY	20.06 Million INR	107.15%
2011 FY	9.68 Million INR	-64.59%
2011 Q4	9.68 Million INR	0.0%
2010 FY	27.35 Million INR	113.32%
2010 Q4	27.35 Million INR	0.0%
2009 FY	12.82 Million INR	158.0%
2008 FY	4.96 Million INR	0.0%
2008 Q4	4.96 Million INR	0.0%

Peer Long Term Debt Comparison of Titan Biotech Limited

Name	Long Term Debt	Long Term Debt Difference
Alfavision Overseas (India) Limited	1.35 Billion INR	99.666%
Biocon Limited	129.32 Billion INR	99.996%
Blue Jet Healthcare Limited	3.79 Million INR	-19.604%
Concord Biotech Limited	18.87 Million INR	75.978%
Dishman Carbogen Amcis Limited	2.45 Billion INR	99.815%
FERMENTA BIOTECH LIMITED	425.36 Million INR	98.934%
GENOMIC VALLEY BIOTECH LIMITED	- INR	-Infinity%
Lyka Labs Limited	429.06 Million INR	98.944%
Panacea Biotec Limited	209.9 Million INR	97.84%
SAMSRITA LABS LIMITED	- INR	-Infinity%
Servoteach Industries Limited	5059.00 INR	-89502.688%
SMS Lifesciences India Limited	331.45 Million INR	98.632%
Supriya Lifescience Limited	50.2 Million INR	90.97%
Syngene International Limited	1 Billion INR	99.547%
TAKE Solutions Limited	7.5 Million INR	39.56%
Transgene Biotek Limited	50.79 Million INR	91.076%
Vanta Bioscience Limited	488.01 Million INR	99.071%